Safety, tolerability, and efficacy of orally administered cannabinoids in MS
- PMID: 12011290
- DOI: 10.1212/wnl.58.9.1404
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
Abstract
The authors conducted a randomized, double-blind, placebo-controlled, twofold crossover study in 16 patients with MS who presented with severe spasticity to investigate safety, tolerability, and efficacy of oral Delta(9)-Tetrahydrocannabinol (THC) and Cannabis sativa plant extract. Both drugs were safe, but adverse events were more common with plant-extract treatment. Compared with placebo, neither THC nor plant-extract treatment reduced spasticity. Both THC and plant-extract treatment worsened the participant's global impression.
Comment in
-
Cannabinoids in MS: potentially useful but not just yet!Neurology. 2002 May 14;58(9):1323-4. doi: 10.1212/wnl.58.9.1323. Neurology. 2002. PMID: 12011274 No abstract available.
-
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.Neurology. 2003 Feb 25;60(4):729-30; author reply 729-30. doi: 10.1212/wnl.60.4.729-a. Neurology. 2003. PMID: 12601130 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical